Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
13 pending office actions • 5 clients • 12 examiners • 6 art units • 0 of 13 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
POLSINELLI and DUKE UNIVERSITY has 491 career applications in Biotechnology & Pharmaceuticals. The firm has a resolved allowance rate of 71.43 percent. Prosecution involves an average of 4.21 office actions per allowance. There are 12 pending office actions currently.
The 71.43 percent allowance rate is a key performance metric. The 4.21 office actions per allowance figure indicates a more intensive prosecution process. With 491 career applications, the data provides a clear view of the firm's work for this client. The average of 4.21 office actions suggests that securing patents for this portfolio requires extensive negotiation and persistence.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (23%) |
| Double-patenting + other | 3 (23%) |
| Multi-statute (no §101) | 7 (54%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GRABER, JAMES J | 2 | 46.7% | +57.7% |
| KELLY, ROBERT M | 1 | 74.1% | +24.6% |
| JACKSON, SHAWQUIA | 1 | 78.0% | -3.3% |
| COUGHLIN, MATTHEW P | 1 | 71.3% | +12.4% |
| NOTTINGHAM, KYLE GREGORY | 1 | 61.7% | +31.9% |
| CHENG, KAREN | 1 | 76.3% | +26.7% |
| CHEN, PO-CHIH | 1 | 74.2% | +14.8% |
| SPENCER, ANDREA LYNNE MORRIS | 1 | 22.2% | +35.7% |
| KELLY-O'NEILL, YOLANDA LYNNETTE | 1 | 33.3% | +29.9% |
| DENT, ALANA HARRIS | 1 | 44.2% | +32.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17637760 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL PAIN AND ITCH | GRABER, JAMES J | 15d |
| 18860428 | BIOMATERIALS FOR IMPROVING BRAIN HEALING AFTER STROKE AND METHODS OF USING SAME | KELLY, ROBERT M | — |
| 18849279 | COMPOSITIONS FOR AND METHODS OF MODULATING RNA STABILITY | JACKSON, SHAWQUIA | — |
| 18626187 | ANTIBIOTICS COMPRISING LPXH-TARGETING COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | CHENG, KAREN | — |
| 18560394 | Compositions For and Methods of Treating and/or Preventing Pain | CHEN, PO-CHIH | — |
| 18547332 | Compositions For and Methods of Improving Gene Therapy | GRABER, JAMES J | — |
| 18269622 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING GLYCOGEN STORAGE DISEASES | SPENCER, ANDREA LYNNE MORRIS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17637760 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL PAIN AND ITCH | GRABER, JAMES J | 15d |
| 18312719 | SYSTEMS AND METHODS FOR PROMOTING REMYELINATION WITH FACTORS DERIVED FROM UMBILICAL CORD BLOOD MACROPHAGES | DENT, ALANA HARRIS | 20d |
| 18860428 | BIOMATERIALS FOR IMPROVING BRAIN HEALING AFTER STROKE AND METHODS OF USING SAME | KELLY, ROBERT M | — |
| 18818163 | BENZOYLGLYCINE DERIVATIVES AND METHODS OF MAKING AND USING SAME | COUGHLIN, MATTHEW P | — |
| 18662751 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | NOTTINGHAM, KYLE GREGORY | — |
| 18626187 | ANTIBIOTICS COMPRISING LPXH-TARGETING COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | CHENG, KAREN | — |
| 18560394 | Compositions For and Methods of Treating and/or Preventing Pain | CHEN, PO-CHIH | — |
| 18547332 | Compositions For and Methods of Improving Gene Therapy | GRABER, JAMES J | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Duke University | 9 |
| UNC Chapel Hill | 1 |
| Sisu Pharma, Inc. | 1 |
| Sanford Burnham Prebys Medical Discovery Inst. | 1 |
| NATIONAL UNIVERSITY OF SINGAPORE | 1 |
| Art Unit | Apps |
|---|---|
| 1631 | 3 |
| 1621 | 1 |
| 1692 | 1 |
| 1643 | 1 |
| 1624 | 1 |
| 1638 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18860428 | BIOMATERIALS FOR IMPROVING BRAIN HEALING AFTER STROKE AND METHODS OF USING SAME | Duke University | KELLY, ROBERT M | §103§112 | Non-Final OA | — | Pending | Oct 25, 2024 | |
| 18849279 | COMPOSITIONS FOR AND METHODS OF MODULATING RNA STABILITY | Duke University | JACKSON, SHAWQUIA | §102§112 | Non-Final OA | — | Pending | Sep 20, 2024 | |
| 18818163 | BENZOYLGLYCINE DERIVATIVES AND METHODS OF MAKING AND USING SAME | The University of North Carolina at Chapel Hill | COUGHLIN, MATTHEW P | §112DP | Non-Final OA | — | Pending | Aug 28, 2024 | |
| 18662751 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | Sisu Pharma, Inc. | NOTTINGHAM, KYLE GREGORY | §102DP | Non-Final OA | — | Pending | May 13, 2024 | |
| 18626187 | ANTIBIOTICS COMPRISING LPXH-TARGETING COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | Duke University | CHENG, KAREN | §102§103 | Non-Final OA | — | Pending | Apr 03, 2024 | |
| 18560394 | Compositions For and Methods of Treating and/or Preventing Pain | Sanford Burnham Prebys Medical Discovery Inst. | CHEN, PO-CHIH | 1621 | §102§103§112Other | Non-Final OA | — | Pending | Nov 12, 2023 |
| 18547332 | Compositions For and Methods of Improving Gene Therapy | Duke University | GRABER, JAMES J | 1631 | §102§103 | Non-Final OA | — | Pending | Aug 21, 2023 |
| 18269622 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING GLYCOGEN STORAGE DISEASES | Duke University | SPENCER, ANDREA LYNNE MORRIS | 1631 | §103§112 | Non-Final OA | — | Pending | Jun 26, 2023 |
| 18200156 | Methods and Compositions for the Treatment of Steatosis-Associated Disorders | National University Of Singapore | KELLY-O'NEILL, YOLANDA LYNNETTE | 1692 | §103 | Final Rejection | — | Pending | May 22, 2023 |
| 18312719 | SYSTEMS AND METHODS FOR PROMOTING REMYELINATION WITH FACTORS DERIVED FROM UMBILICAL CORD BLOOD MACROPHAGES | Duke University | DENT, ALANA HARRIS | 1643 | §102§103DP | Final Rejection | 20d | Pending | May 05, 2023 |
| 17912429 | COMPOSITIONS AND METHODS FOR TREATMENT OF PATHOLOGIC PAIN ASSOCIATED WITH MALIGNANT GROWTH DISORDER | Duke University | MOORE, SUSANNA | 1624 | §103 | Final Rejection | — | Pending | Sep 16, 2022 |
| 17637760 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL PAIN AND ITCH | Duke University | GRABER, JAMES J | 1631 | §103§112 | Final Rejection | 15d | Pending | Feb 23, 2022 |
| 16477110 | Methods of Treating Brain Injury Using Cord Blood or a Component Thereof | Duke University | WILSON, MICHAEL C | 1638 | §103 | Final Rejection | — | Pending | Jul 10, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial